基本信息
文件名称：Naloxegol-13C-d2-NKTR-118-sup-13-sup-C-sub-d-sub-2-sub-生命科学试剂-MCE.pdf
文件大小：459.23 KB
总页数：1 页
更新时间：2025-05-22
总字数：约2.98千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Naloxegol-13C,d2

Cat.No.:HY-A0118S1

Synonyms:NKTR-118-13C,d;AZ13C

2,d2

分?式:C????CH??D?NO??

分?量:654.79

作?靶点:Isotope-LabeledCompounds;OpioidReceptor

作?通路:Others;GPCR/GProtein;NeuronalSignaling

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Naloxegol-13C,d2(NKTR-118-13C,d2)是13C标记的Naloxegol.Naloxegol(NKTR-118;AZ是?

种μ-阿?受体拮抗剂。Naloxegol能抑制阿?结合胃肠道μ-阿?受体，能有效减轻阿?类药物引起的便秘

[1][2]。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

REFERENCES

[1].RussakEM,etal.Impacto